Skip to main content

Is My Product Recalled?

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Scan How It Works Saved Get Alerts

Menu

Search All Recalls Latest Recalls Scan Barcode Get Alerts

Categories

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Resources

How Recalls Work FAQ Recall Classifications Statistics & Trends About

Your Recalls

Loading...

Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Home
/
Brands
/
Marlex Pharmaceuticals, Inc.

Marlex Pharmaceuticals, Inc. Recalls

All product recalls associated with Marlex Pharmaceuticals, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

1000

Past Year

1000

Class I (Serious)

34

Most Recent

Jan 2026

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 15301–15320 of 21320 recalls

Acetaminophen Tablets (Marlex) – manufacturing deviation (2013)

CGMP Deviations: The recalled acetaminophen tablet lot was not manufactured under current good manufacturing practices as noted by a recent inspection of the manufacturing firm.

Class IIModerate

FDAAug 8, 2013Nationwide• Marlex Pharmaceuticals, Inc.

K Effervescent Tablets (Qualitest) – label mix-up (2013)

LABELING: Label Mix-up: 30 count Effervescent Potassium/Chloride Tablets, may be labeled as 30 count K Effervescent Tablets.

Class IIModerate

FDAAug 8, 2013Nationwide• Qualitest Pharmaceuticals

Diovan (Novartis) – chemical contamination (2013)

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

1...764 765766767 768...1066

Page 766 of 1066Next

Class IIModerate

FDAAug 8, 2013Nationwide• Novartis Pharmaceuticals Corp.

Exforge (Novartis) – Chemical Contamination (2013)

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

Class IIModerate

FDAAug 8, 2013Nationwide• Novartis Pharmaceuticals Corp.

Diovan (Novartis) – Chemical Contamination (2013)

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

Class IIModerate

FDAAug 8, 2013Nationwide• Novartis Pharmaceuticals Corp.

Exforge (Novartis) – chemical contamination (2013)

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

Class IIModerate

FDAAug 8, 2013Nationwide• Novartis Pharmaceuticals Corp.

Exforge HCT (Novartis) – chemical contamination (2013)

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

Class IIModerate

FDAAug 8, 2013Nationwide• Novartis Pharmaceuticals Corp.

IC Bus CASB (IC Bus) – Seat Installation Problem (2013)

Navistar, Inc. is recalling certain model year 2013-2014 IC Bus AE, and 2011-2014 BE, CE, and RE buses. These buses were manufactured February 11, 2010, through June 17, 2013. The passenger seat foam padding did not adequately reduce the impact forces to the knee in the lower outside corners of the seat back during compliance testing. Thus, these buses fail to conform to the requirements of Federal Motor Vehicle Safety Standard (FMVSS) No. 222, "School Bus Passenger Seating and Crash Protection."

NHTSAAug 7, 2013Nationwide• IC BUS

Propranolol Tablets (Teva) – tablet specification (2013)

Failed Tablet/Capsule Specification: Teva is recalling certain lots of Propanolol HCl Tablets, 10 mg due to the potential of some tablets not conforming to weight specification.

Class IIModerate

FDAAug 6, 2013Nationwide• Teva Pharmaceuticals USA, Inc.

Valacyclovir HCl Tablets (American Health) – Potency Issue (2013)

Subpotent

Class IIModerate

FDAAug 2, 2013Nationwide• American Health Packaging

Benztropine Mesylate Injection (Nexus) – Glass Delamination (2013)

Presence of particulate matter: characterized as thin colorless flakes that are visually and chemically consistent with glass delamination.

Class IIModerate

FDAAug 1, 2013Nationwide• Nexus Pharmaceuticals Inc

Kensington Court Heels (JP Boden) – fall hazard (2013)

The Kensington Court 3 1/2 inch high heel patent leather shoes were sold in four colors including dark blue with beige trim, cream with tan trim, red with gray trim and turquoise blue with beige trim. The plain toe pump women's shoes were sold in sizes 5-1/2 to 10-1/2. The Boden logo is printed on a label on the inside sole of the shoe.

CPSCJul 31, 2013Nationwide• JP Boden Services Inc., of Pittston, Pa.

Belladonna Alkaloids Tablets (West-Ward) – Foreign Substance (2013)

Presence of Foreign Substance: black specks comprised of degraded organic material found on tablets

Class IIModerate

FDAJul 30, 2013Nationwide• West-Ward Pharmaceutical Corp.

Lisinopril Tablets (West-Ward) – Impurity Specification (2013)

Failed Impurities/Degradation Specifications: Out of Specification results for Individual Other Unknown Related Compounds were obtained at the 48 month time-point.

Class IIModerate

FDAJul 30, 2013Nationwide• West-Ward Pharmaceutical Corp.

Paraben Water (Beacon Hill) – Sterility Concerns (2013)

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Class IIModerate

FDAJul 26, 2013Nationwide• Beacon Hill Medical Pharmacy, P.C.

Glutathione (Beacon Hill) – Sterility Concerns (2013)

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Class IIModerate

FDAJul 26, 2013Nationwide• Beacon Hill Medical Pharmacy, P.C.

Zinc Sulfate Injectable (Beacon Hill Medical) – Sterility Concerns (2013)

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Class IIModerate

FDAJul 26, 2013Nationwide• Beacon Hill Medical Pharmacy, P.C.

Calcium EDTA (Beacon Hill) – Sterility Concerns (2013)

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Class IIModerate

FDAJul 26, 2013Nationwide• Beacon Hill Medical Pharmacy, P.C.

Calcium EDTA (Beacon Hill) – Sterility Concerns (2013)

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Class IIModerate

FDAJul 26, 2013Nationwide• Beacon Hill Medical Pharmacy, P.C.

Dexamethasone Sodium Phosphate (Beacon Hill) – Sterility Concerns (2013)

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Class IIModerate

FDAJul 26, 2013Nationwide• Beacon Hill Medical Pharmacy, P.C.